Literature DB >> 22068615

Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS).

A N Schüring1, A Welp, J Gromoll, M Zitzmann, B Sonntag, E Nieschlag, R R Greb, L Kiesel.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a frequent heterogenic disorder with a familial background. Androgenic effects, determining the clinical features of the syndrome, are mediated by the androgen receptor (AR), whose activity is modulated by a genetic polymorphism. We investigated the role of the CAG repeat polymorphism of the androgen receptor in PCOS.
METHODS: In the infertility unit of a university clinic, 72 PCOS patients were compared with 179 ovulatory controls undergoing a standardized diagnostic work-up. The number of CAG repeats was determined by PCR, labelling with IR-800 and PAGE. X-chromosome inactivation was assessed by a methylation-sensitive assay.
RESULTS: Compared to controls, PCOS patients displayed a shorter mean CAG repeat length, encoding for higher AR activity (P=0.001). CAG repeat length correlated inversely with oligomenorrhea, a central androgen dependent feature of the syndrome (P=0.005). In a binomial regression analysis including BMI, LH and free testosterone, CAG repeat length was identified as an independent risk factor for PCOS (P=0.002).
CONCLUSIONS: The CAG repeat polymorphism could constitute one of the genetic factors modulating the syndrome's phenotype, contributing to its clinical heterogeneity and associated metabolic consequences. © J. A. Barth Verlag in George Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22068615     DOI: 10.1055/s-0031-1291343

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  19 in total

1.  The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis.

Authors:  Cui Ying Peng; Hui Jun Xie; Zi Fen Guo; Yu Lin Nie; Jun Chen; Jun Mei Zhou; Jie Yin
Journal:  J Assist Reprod Genet       Date:  2014-07-02       Impact factor: 3.412

2.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

3.  Developmental Programming: Contribution of Epigenetic Enzymes to Antral Follicular Defects in the Sheep Model of PCOS.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Robert C Thompson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

4.  Androgen Receptor Coregulator CTBP1-AS Is Associated With Polycystic Ovary Syndrome in Chinese Women: A Preliminary Study.

Authors:  Zhenteng Liu; Cuifang Hao; Dehua Song; Ning Zhang; Hongchu Bao; Qinglan Qu
Journal:  Reprod Sci       Date:  2014-12-31       Impact factor: 3.060

Review 5.  Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.

Authors:  Rui Wang; Mark O Goodarzi; Ting Xiong; Di Wang; Ricardo Azziz; Hanwang Zhang
Journal:  Mol Hum Reprod       Date:  2012-06-12       Impact factor: 4.025

6.  DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS.

Authors:  Bárbara Echiburú; Fermín Milagro; Nicolás Crisosto; Francisco Pérez-Bravo; Cristian Flores; Ana Arpón; Francisca Salas-Pérez; Sergio E Recabarren; Teresa Sir-Petermann; Manuel Maliqueo
Journal:  Epigenetics       Date:  2020-04-20       Impact factor: 4.528

7.  Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.

Authors:  Genevieve E Ryan; Shaddy Malik; Pamela L Mellon
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

8.  Head-To-Head Assessment of Diagnostic Performance of Testosterone Immunoassays in Patients With Polycystic Ovary Syndrome.

Authors:  Andreas N Schüring; Stefan Nolte; Manfred Fobker; Frank Kannenberg; Jerzy-Roch Nofer
Journal:  J Clin Lab Anal       Date:  2015-10-26       Impact factor: 2.352

9.  Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS).

Authors:  Singh Rajender; Silas Justin Carlus; Sandeep Kumar Bansal; Mahendra Pal Singh Negi; Mahendra Pratap Singh Negi; Nirmala Sadasivam; Muthusamy Narayanan Sadasivam; Kumarasamy Thangaraj
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

10.  The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS.

Authors:  N Baculescu
Journal:  J Med Life       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.